Aggamin Pharmaceuticals, LLC

New York, NY 10032

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $2.56MM
First Award Date 09/01/13
Most Recent Award Date 05/05/17

Key Personnel

Last Name Name Awards Contact
Joo Woo Joo 3
TAN ADELENE TAN 2

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 05/05/17 - 04/30/18

Preeclampsia (PE) is a pregnancy-induced hypertensive disorder without an effective treatment. The goal of this project is to produce a safe and effective biologic for treatment of very preterm PE. PE is the leading cause of pregnancy-related morbidity and mortality in the US, affecting over 200,000 pregnant women and newborns annually, at a sig...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 04/01/16 - 03/31/17
PI: Woo Joo

? DESCRIPTION (provided by applicant): Preeclampsia (PE) is a pregnancy-induced hypertensive disorder without an effective treatment. The goal of this project is to produce a novel apheresis therapy for treatment of PE. PE is the leading cause of pregnancy- related mortality and morbidity in the US, affecting over 200,000 pregnant women and n...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 04/01/15 - 03/31/16
PI: Woo Joo

DESCRIPTION (provided by applicant): Preeclampsia (PE) is a pregnancy-induced hypertensive disorder without an effective treatment. The goal of this project is to produce a novel apheresis therapy for treatment of PE. PE is the leading cause of pregnancy- related mortality and morbidity in the US, affecting over 200,000 pregnant women and newbor...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HD-14-031
Budget: 09/25/14 - 03/24/15

DESCRIPTION (provided by applicant): ABSTRACT Preeclampsia (PE) is a pregnancy-induced hypertensive disorder without an effective treatment. The goal of this project is to produce a novel biologic for treatment of PE. PE is the leading cause of pregnancy-related morbidity and mortality in the US, affecting over 200,000 pregnant women and newborn...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/01/13 - 04/30/14
PI: Woo Joo

DESCRIPTION (provided by applicant): Preeclampsia (PE) is a pregnancy-induced hypertensive disorder without an effective treatment. The goal of this project is to produce a novel and safe therapy for PE. PE is the leading cause of pregnancy-related morbidity and mortality in the US, affecting over 200,000 pregnant women and newborns annually, at...